procyanidin has been researched along with MS (Multiple Sclerosis) in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, H; Endo, K; Haga, H; Isono, M; Makabe, H; Masaki, A; Niitsuma, F; Rizeq, L; Saiki, T; Sawa, T; Tanaka, S; Tanaka, Y | 1 |
| Amarenco, G; Benoit, N; Bonniaud, V; de Seze, M; Denys, P; Donzé, C; Gallien, P; Kerdraon, J; Naudet, F; Renault, A; Reymann, JM | 1 |
| Hussar, DA | 1 |
| Gomez, CS; Jahromi, MS; Mure, A | 1 |
1 review(s) available for procyanidin and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
UTIs in patients with neurogenic bladder.
Topics: Administration, Intravesical; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Antioxidants; Ascorbic Acid; Botulinum Toxins, Type A; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Immunotherapy, Active; Mannose; Methenamine; Multiple Sclerosis; Neuromuscular Agents; Proanthocyanidins; Probiotics; Recurrence; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Catheters; Urinary Tract Infections | 2014 |
1 trial(s) available for procyanidin and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
Topics: Adult; Anti-Infective Agents; Double-Blind Method; Female; France; Fruit; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis; Phytotherapy; Plant Extracts; Plants, Medicinal; Proanthocyanidins; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Urinary Tract Infections; Vaccinium macrocarpon | 2014 |
2 other study(ies) available for procyanidin and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Oral administration of procyanidin B2 3,3"-di-O-gallate ameliorates experimental autoimmune encephalomyelitis through immunosuppressive effects on CD4
Topics: Administration, Oral; Animals; CD4-Positive T-Lymphocytes; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Proanthocyanidins; T-Lymphocytes | 2023 |
New drugs 2014, part 1.
Topics: Abatacept; Adult; Anticoagulants; Antidiarrheals; Antitubercular Agents; Benzazepines; Canagliflozin; Dimethyl Fumarate; Dipeptidyl-Peptidase IV Inhibitors; Drug Approval; Dyspareunia; Humans; Hypoglycemic Agents; Multiple Sclerosis; Obesity; Oligonucleotides; Piperidines; Proanthocyanidins; Tamoxifen; Uracil | 2014 |